Jenapharm
- Company typePrivate
- Founded1942
- HeadquartersJena, Germany
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
Jenapharm firmographics
Firmographics- Name
- Jenapharm
- Legal name
- Bayer Vital GmbH
- Website
- https://jenapharm.de
- Company type
- Private
- Founded year
- 1942
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Jenapharm industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)
- akta.pro secondary industries
- Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
Keywords
Where Jenapharm is headquartered
LocationHeadquarters
- HQ city
- Jena
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Jenapharm business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Revenue model
- Pharmaceutical Product Sales: Jenapharm generates revenue through the sale of prescription and over-the-counter pharmaceutical products across multiple therapeutic areas including contraception, menopause treatment, endometriosis, erectile dysfunction, and dermatological conditions. Products are distributed through pharmacies in Germany.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Prescription pharmaceuticals |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Jenapharm product offering
Product offeringCore offering
Jenapharm is a German pharmaceutical brand that develops, markets and distributes prescription and OTC medications for women's health (oral and long-acting contraceptives, menopause hormone replacement therapy, endometriosis treatment), men's health (erectile dysfunction therapy) and dermatological conditions (antiandrogen acne treatment). Products are sold under the Jenapharm label through Bayer Vital GmbH's distribution network and dispensed via pharmacies across Germany, supported by patient apps, self-assessment tools and physician finder services.
Product overview
Jenapharm, operating as a division of Bayer Vital GmbH, is a German pharmaceutical company specializing in products for women’s health and men’s health. The portfolio includes oral contraceptives (such as 28 mini®, Microgynon®, Yasmin®, Qlaira®), long-acting reversible contraceptives (intrauterine systems like Mirena®, KyleenaTM, Jaydess®, and copper IUDs Nova T® 380 and NovaStep®), menopause hormone replacement therapies (Progynova®, Lafamme®, Angeliq®, Climen®), endometriosis treatment (Visanne® 2 mg), erectile dysfunction treatments (Levitra® film-coated and orodispersible tablets), and dermatological products (Diane®-35). The company also offers digital health apps including Qlaira app, Pillenalarm, and Pill Reminder for contraception support, along with self-check tools for menopause symptoms and erectile dysfunction (IIEF questionnaire).
Differentiator
Problem solved
Functional benefit
Brands
- Qlaira App: Mobile application for Qlaira users
- Pillenalarm
- Pill Reminder
Products and services
- 28 mini Oral contraceptive pill for pregnancy prevention.
Companies that use Jenapharm
Customer profileSegments3 records
Ideal customer profiles3 records
Jenapharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Jenapharm partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor.
- Gynfakultaet (Gynäkologische Fakultät)minorGynfakultaet serves as a service partner for gynecologists, providing a bestellshop for ordering service materials and professional resources. Jenapharm directs healthcare professionals to this platform for service material ordering.
- MFA-GynAkademieminorMFA-GynAkademie serves medical assistants (MFA) in gynecological practices with training offers, service concepts, and a bestellshop for service materials. Jenapharm directs this audience to the platform.
- Frauenaerzte.de (Gynecologist Finder)minorExternal physician search portal helping patients find gynecologists. Jenapharm links to this service to help patients locate healthcare providers for consultations.
- Maenneraerzte.de (Men's Health Physician Finder)minorExternal physician search portal helping patients find urologists and general practitioners specializing in men's health. Jenapharm links to this service for male health products.
Scale indicators1 record
Recent moves1 record
Expansion highlights4 records
Jenapharm competitors and assessment
Company assessmentDirect peers
- Hexal AG: German generics leader (Sandoz subsidiary) offering generic oral contraceptives and HRT products. Direct competitor in the German pharmacy channel and a key pricing pressure point for Jenapharm's branded portfolio.
- Organon & Co. Global women's health pharmaceutical company spun off from Merck, focused on contraception, fertility, and menopause therapies. Direct overlap with Jenapharm's core women's health portfolio across contraception, HRT, and reproductive health.
- Gedeon Richter Pharma GmbH: European pharmaceutical company with a strong women's health franchise including oral contraceptives and HRT products. Competitor to Jenapharm in the German gynecology market.
- Theramex Germany: Women's health pharmaceutical company focused on contraception, menopause, and reproductive health. Direct competitor in the German market across Jenapharm's core therapeutic categories.
- Exeltis Germany: Specialty pharmaceutical company focused on women's health, with oral contraceptives and HRT products. Competitor in the German gynecology prescribing channel.
Regional players
- Stada Arzneimittel AG: German-headquartered generics and specialty pharmaceutical company with women's health offerings. Regional competitor in the German pharmacy channel, particularly in generic and value-segment contraceptives.
Broad incumbents
- Pfizer Pharma GmbH: Large pharmaceutical incumbent with a broad women's health and men's health portfolio, including competing products in the German prescription market. Overlaps with Jenapharm across multiple therapeutic categories but as part of a wider portfolio.
- AbbVie Deutschland: Global pharmaceutical incumbent with women's health franchises (post-Allergan) including contraception and endometriosis products. Competes with Jenapharm in gynecology as part of a broader portfolio.
- Merck KGaA Healthcare: Global pharmaceutical company with fertility and reproductive health products (e.g., Gonal-f, Cetrotide). Overlaps with Jenapharm's reproductive health positioning in the German market as a broader portfolio player.
Peers
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Jenapharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jenapharm leadership team
Management profileNumber of profiles
Profiles1 record
Jenapharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jenapharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jenapharm
What does Jenapharm do?
Jenapharm is a German pharmaceutical brand that develops, markets and distributes prescription and OTC medications for women's health (oral and long-acting contraceptives, menopause hormone replacement therapy, endometriosis treatment), men's health (erectile dysfunction therapy) and dermatological conditions (antiandrogen acne treatment). Products are sold under the Jenapharm label through Bayer Vital GmbH's distribution network and dispensed via pharmacies across Germany, supported by patient apps, self-assessment tools and physician finder services.
Is Jenapharm a public or private company?
Jenapharm is a private company. It is classified as corporate owned and is currently operating.
When was Jenapharm founded?
Jenapharm was founded in 1942. It employs 11 to 50 people.
Where is Jenapharm based?
Jenapharm is headquartered in Jena, Germany, in the Europe region.
How does Jenapharm make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Jenapharm's main competitors?
Direct peers on record are Hexal AG, Organon & Co., Gedeon Richter Pharma GmbH, Theramex Germany and Exeltis Germany. Stada Arzneimittel AG is listed as a regional player. Broad incumbents are Pfizer Pharma GmbH, AbbVie Deutschland and Merck KGaA Healthcare. Schering AG (legacy/Bayer) is listed as a peer.
Does Jenapharm have an API?
No public API is recorded for Jenapharm.
What industry is Jenapharm in?
Jenapharm's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health), with a secondary code of HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.